NCT05432596Phase 2Completed

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Study sponsor: Aclaris Therapeutics, Inc. · ACRS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-10-26Actual
Enrollment · participants250Actual
Source updated2024-10-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview